ATIRATECAN
UNII B0AMG37FFR

Substance Identification & Data

This profile provides standardized clinical and technical data for Atiratecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B0AMG37FFR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 867063-97-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B0AMG37FFR

CAS Registry Number

867063-97-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ATIRATECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C31H34N6O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CWJSAEZZZABNRI-HKBQPEDESA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C90995

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11592352

Unique identification number in the NCBI database of chemical substances.

INN ID

9072

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@]1(c2c(c(n3Cc4c(-c3c2)nc5c6c4N(C=Nc6ccc5)CCCCC)=O)COC1=O)(CC)OC(CN(C(CN)=O)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atiratecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ATIRATECAN

Common Names & Synonyms

(9S)-9-ETHYL-10,13-DIOXO-1-PENTYL-9,10,13,15-TETRAHYDRO-1H,12HPYRANO(3'',4'':6',7')INDOLIZINO(2',1':5,6)PYRIDO(4,3,2-DE)QUINAZOLIN-9-YL GLYCYL-N-METHYLGLYCINATE

ATIRATECAN [INN]

ATIRATECAN [WHO-DD]